Skip to main content
[Preprint]. 2024 Jul 26:rs.3.rs-4510870. [Version 1] doi: 10.21203/rs.3.rs-4510870/v1

Figure 1.

Figure 1

Kaplan-Meier curve demonstrating the association of SGLT2 inhibitors with higher survival probability from acute myocardial infarction, heart failure, peripheral artery disease and all-cause mortality among patients with prostate cancer on hormone therapy compared to propensity matched patients treated with other antidiabetic therapies.